You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Phase II: Development of Low-Cost, Shelf-Stable Treatment for Tuberculosis
SBC: VIA THERAPEUTICS, LLC Topic: 97To develop and test a low-cost, easy-to-administer drug formulation intended for use in treating rifampicin-resistant pulmonary tuberculosis in pediatric patient populations.
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
CLINICAL VERIFICATION AND VALIDATION OF A WEARABLE NEAR-INFRARED BLOOD ALCOHOL CONTENT MONITOR.
SBC: VIVONICS INC Topic: 18CLINICAL VERIFICATION AND VALIDATION OF A WEARABLE NEAR-INFRARED BLOOD ALCOHOL CONTENT MONITOR.
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Reagents for Immunologic Analysis of Under-represented Mammalian Models
SBC: INTEGRAL MOLECULAR INC Topic: 118Integral Molecular proposes to generate a large panel of pan-reactive monoclonal antibodies (mAbs) against immune cell markers to be used instudies of immune function and responses in nine underrepresented mammalian models. Since certain mammalian models display many features of human immunity but are similarly underutilized due to lack of immunologic reagents, development of cross-reacting antibo ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
FY23. SBIR TOPIC 167 PHASE I: ULTRAPORTABLE LAB-ON-A-CHIP BIOSENSOR SYSTEM FOR RAPID POSTMORTEM TOXICOLOGY. PERIOD OF PERFORMANCE: 9/27/23-9/26/24
SBC: PORTABLE DIAGNOSTIC SYSTEMS INC Topic: 167Currently, suspected drug overdoses represent more than 1 in 6 death investigations, and both coroner and medical examiner offices are facing overwhelming caseloads that require comprehensive toxicology analysis. Therefore, there is a critical and immediate need to improve the workflow in suspected fatal overdose cases with new postmortem toxicology screening tools. This Phase I project from Porta ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
COGNITIONCARE: A NOVEL AI/ML TOOL FOR EXPLORING CAUSAL RELATIONSHIPS IN AD/ADRD-FOCUSED BSR LITERATURE
SBC: LEXICAL INTELLIGENCE, LLC Topic: 9The objective of this contract is to develop a tool that allows researchers to identify preventions for AD/ADRD through access to and analysis of the vast array of BSR literature. Cognition Causal Association Record Extractor (CognitionCARE) is an AI-based web application that presents AD/ADRD-specific, BSR-related information in a manner that is easy to consume and act upon. CognitionCARE extract ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
SBIR- TOPIC 009- AI/ML TOOL FOR VISUALIZING BEHAVIORAL AND SOCIAL SCIENCE RESEARCH
SBC: HYPERTHESIS, LLC Topic: 9The purpose of this project is to develop an AI-based tool for Behavioral and Social Science Research (BSR) - specific literature visualization and hypothesis discovery that might be marketed ultimately to various institutions that consume scientific research, with an emphasis on Alzheimer's disease. Such a tool would likely reduce the time for understanding the conceptual structure of the literat ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF AUTOMATED CELL CULTURE FLASK CLEANING INSTRUMENT LYNNTECH INC:1109527 [23-004993]
SBC: LYNNTECH INC. Topic: 23The scope of this effort will be focused on activities that have the potential to provide proof-of-concept for the proposed AC3D approach.
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Immersive and Interactive VR Platform for Quantitative Telehealth Rehabilitation of Rare Diseases
SBC: ALTEC, INC Topic: 20To develop a multi-modal virtual reality environment for remote use, enabling physicians and healthcare providers to guide rare disease patient therapy while automatically obtaining crucial health metrics.
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of Patient Care Environment through Immersive Virtual Reality
SBC: CFD RESEARCH CORPORATION Topic: 20To develop an immersive VR environment where clinicians can interact with patients with rare diseases using virtual avatars.
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT OF SNOW CLEANING WITH SUPERCRITICAL CO2
SBC: INTELLIGENT OPTICAL SYSTEMS, INC. Topic: 23A prototype instrument will be constructed to clean, sterilize, and enable fully viable reuse of tissue culture polystyrene (TCPS) vessels such as T-flasks.
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health